Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI. | Cardiovasc Drugs Ther | 2023 | 35567726 | PubTator, text mining | PubMed |
| Spatial Stochastic Model of the Pre-B Cell Receptor. | IEEE/ACM Trans Comput Biol Bioinform | 2023 | 35482702 | PubTator, text mining | PubMed |
| Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts. | Cancer Res Treat | 2023 | 35468269 | PubTator, text mining | PubMed |
| A novel differential diagnosis algorithm for chronic lymphocytic leukemia using immunophenotyping with flow cytometry. | Hematol Transfus Cell Ther | 2023 | 35216960 | PubTator, text mining | PubMed |
| Anti-CD20-atezolizumab-polatuzumab vedotin in relapsed/refractory follicular and diffuse large B-cell lymphoma. | J Cancer Res Clin Oncol | 2023 | 35182224 | PubTator, text mining | PubMed |
| Cold agglutinin syndrome secondary to splenic marginal zone lymphoma: a case report. | Hematol Transfus Cell Ther | 2023 | 34836848 | PubTator, text mining | PubMed |
| Prevalence and prognostic value of MYD88 and CD79B mutations in ocular adnexal large B-cell lymphoma: a reclassification of ocular adnexal large B-cell lymphoma. | Br J Ophthalmol | 2023 | 34706861 | PubTator, text mining | PubMed |
| Expert consensus on the clinical application of antibody-drug conjugates in the treatment of malignant tumors (2021 edition). | Cancer Innov | 2022 | 38089450 | PubTator, text mining | PubMed |
| Research highlights of clinical oncology early 2022. | Holist Integr Oncol | 2022 | 37520335 | PubTator, text mining | PubMed |
| Single-cell transcriptomic landscape identifies the expansion of peripheral blood monocytes as an indicator of HIV-1-TB co-infection. | Cell Insight | 2022 | 37192986 | PubTator, text mining | PubMed |
| Diffuse large B-cell lymphoma: An uncommon diagnosis at the cerebellopontine angle - A case report. | Brain Circ | 2022 | 37181838 | PubTator, text mining | PubMed |
| Molecular Aspects of Insulin Aggregation and Various Therapeutic Interventions. | ACS Bio Med Chem Au | 2022 | 37101572 | PubTator, text mining | PubMed |
| Treatment for a B-cell acute lymphoblastic leukemia patient carrying a rare TP53 c.C275T mutation: A case report. | Front Oncol | 2022 | 36798689 | PubTator, text mining | PubMed |
| Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2022 | 36748379 | PubTator, text mining | PubMed |
| A rare case report of waldenström macroglobulinemia converted to serum low IgM. | Front Genet | 2022 | 36744182 | PubTator, text mining | PubMed |
| [Clonality relatedness and molecular characteristics of Richter transformation]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709198 | PubTator, text mining | PubMed |
| [Clinical features and prognosis of 166 cases of MYC/BCL2 double-expression diffuse large B-cell lymphoma]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709172 | PubTator, text mining | PubMed |
| [Clinical analysis of 20 cases of small B lymphocyte proliferative disease with t (14;19) (q32;q13)]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709153 | PubTator, text mining | PubMed |
| [Clinical and biological characteristics of non-IgM lymphoplasmacytic lymphoma]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709134 | PubTator, text mining | PubMed |
| Point and counterpoint: Polatuzumab vedotin in the front-line therapy for diffuse large B- cell lymphoma. | Front Oncol | 2022 | 36686842 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=46